A hybrid simulation model of HIV program interventions: from transmission behavior to macroeconomic impacts.

IF 3.4 3区 医学 Q2 PHARMACOLOGY & PHARMACY
Therapeutic Advances in Drug Safety Pub Date : 2025-08-20 eCollection Date: 2025-01-01 DOI:10.1177/20420986251367510
William Crown, Erin Britton, Moaven Razavi, Yiqun Luan, Senthil Veerunaidu, Jennifer Kates, Gary Gaumer, Monica Jordan, Clare L Hurley, Allyala K Nandakumar
{"title":"A hybrid simulation model of HIV program interventions: from transmission behavior to macroeconomic impacts.","authors":"William Crown, Erin Britton, Moaven Razavi, Yiqun Luan, Senthil Veerunaidu, Jennifer Kates, Gary Gaumer, Monica Jordan, Clare L Hurley, Allyala K Nandakumar","doi":"10.1177/20420986251367510","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Considerable progress has been made in the estimation of drug safety treatment effects-particularly with observational medical claims and electronic medical record data. The use of the Target Trial framework, along with developments in statistical methodology such as doubly robust and G-estimation methods, has improved the ability to draw reliable causal inferences about drug and vaccine safety from observational data. However, such models rarely relate drug safety outcomes to other domains such as economic impacts. As shown by the COVID-19 pandemic, this is a significant limitation with potentially serious and long-term consequences.</p><p><strong>Objective: </strong>The goal of this paper is to demonstrate that the availability of simulation tools would enable policy-makers to assess drug safety and effectiveness outcomes associated with alternative policies, as well as examine these effects in the context of other domains, such as economic outcomes.</p><p><strong>Design: </strong>We develop an agent-based simulation model (ABM) of a peer navigator program to support engagement in HIV therapy in Tanzania. Results from the ABM are weighted to reflect the Tanzanian population and fed into the SPECTRUM model. This generates detailed demographic forecasts that are translated into macroeconomic impacts using labor force participation rates from the International Labor Organization, along with an econometric model of gross domestic product.</p><p><strong>Results: </strong>The ABM simulation estimated that the peer navigation program increased ART participation for men and women by about 12%-15% with no strong trend over time. The impact on VLS, however, was cumulative and significant for both men and women. By year 3, VLS was improved by 33.9 percentage points for women and 32.6 percentage points for men. However, the overall impact of these estimates on mortality was modest-ranging from less than 500 lives per year at the start of the forecast period to about 2500 lives per year in 2030. Consequently, the associated macroeconomic impacts were also small. The relatively modest impacts were due to the limited opportunity for HIV control in Tanzania, which had already met its 95/95/95 goals.</p><p><strong>Conclusion: </strong>Although the simulated macroeconomic effects of the peer navigator program in Tanzania were modest, the paper demonstrates the feasibility of linking behavioral ABM simulations of program impacts to subsequent demographic effects and, finally, macroeconomic performance. Moreover, given the clinical response in ART and VLS in the exposed population in Tanzania, it is likely that the same peer navigator intervention conducted in another country with a larger at-risk HIV population would be much larger.</p>","PeriodicalId":23012,"journal":{"name":"Therapeutic Advances in Drug Safety","volume":"16 ","pages":"20420986251367510"},"PeriodicalIF":3.4000,"publicationDate":"2025-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12368329/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Therapeutic Advances in Drug Safety","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/20420986251367510","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Considerable progress has been made in the estimation of drug safety treatment effects-particularly with observational medical claims and electronic medical record data. The use of the Target Trial framework, along with developments in statistical methodology such as doubly robust and G-estimation methods, has improved the ability to draw reliable causal inferences about drug and vaccine safety from observational data. However, such models rarely relate drug safety outcomes to other domains such as economic impacts. As shown by the COVID-19 pandemic, this is a significant limitation with potentially serious and long-term consequences.

Objective: The goal of this paper is to demonstrate that the availability of simulation tools would enable policy-makers to assess drug safety and effectiveness outcomes associated with alternative policies, as well as examine these effects in the context of other domains, such as economic outcomes.

Design: We develop an agent-based simulation model (ABM) of a peer navigator program to support engagement in HIV therapy in Tanzania. Results from the ABM are weighted to reflect the Tanzanian population and fed into the SPECTRUM model. This generates detailed demographic forecasts that are translated into macroeconomic impacts using labor force participation rates from the International Labor Organization, along with an econometric model of gross domestic product.

Results: The ABM simulation estimated that the peer navigation program increased ART participation for men and women by about 12%-15% with no strong trend over time. The impact on VLS, however, was cumulative and significant for both men and women. By year 3, VLS was improved by 33.9 percentage points for women and 32.6 percentage points for men. However, the overall impact of these estimates on mortality was modest-ranging from less than 500 lives per year at the start of the forecast period to about 2500 lives per year in 2030. Consequently, the associated macroeconomic impacts were also small. The relatively modest impacts were due to the limited opportunity for HIV control in Tanzania, which had already met its 95/95/95 goals.

Conclusion: Although the simulated macroeconomic effects of the peer navigator program in Tanzania were modest, the paper demonstrates the feasibility of linking behavioral ABM simulations of program impacts to subsequent demographic effects and, finally, macroeconomic performance. Moreover, given the clinical response in ART and VLS in the exposed population in Tanzania, it is likely that the same peer navigator intervention conducted in another country with a larger at-risk HIV population would be much larger.

Abstract Image

Abstract Image

Abstract Image

艾滋病项目干预的混合模拟模型:从传播行为到宏观经济影响。
背景:在评估药物安全治疗效果方面已经取得了相当大的进展,特别是在观察性医疗索赔和电子病历数据方面。目标试验框架的使用,以及双稳健和g估计方法等统计方法的发展,提高了从观察数据得出关于药物和疫苗安全性的可靠因果推论的能力。然而,这些模型很少将药物安全结果与经济影响等其他领域联系起来。正如2019冠状病毒病大流行所表明的那样,这是一个重大限制,可能会产生严重和长期的后果。目的:本文的目标是证明模拟工具的可用性将使政策制定者能够评估与替代政策相关的药物安全性和有效性结果,以及在其他领域(如经济结果)的背景下检查这些影响。设计:我们开发了一个基于代理的模拟模型(ABM)的同伴导航程序,以支持参与坦桑尼亚的艾滋病毒治疗。ABM的结果经过加权以反映坦桑尼亚人口,并输入SPECTRUM模型。这产生了详细的人口预测,并利用国际劳工组织的劳动力参与率以及国内生产总值的计量经济模型将其转化为宏观经济影响。结果:ABM模拟估计同伴导航计划使男性和女性的ART参与增加了约12%-15%,随着时间的推移没有明显的趋势。然而,对VLS的影响是累积的,对男性和女性都是显著的。到第三年,女性的VLS提高了33.9个百分点,男性提高了32.6个百分点。然而,这些估计对死亡率的总体影响不大,从预测期开始时的每年不到500人到2030年的每年约2500人。因此,相关的宏观经济影响也很小。影响相对较小是由于坦桑尼亚控制艾滋病毒的机会有限,该国已经实现了其95/95/95目标。结论:尽管坦桑尼亚同伴导航员项目的模拟宏观经济效应不大,但本文证明了将项目影响的行为ABM模拟与随后的人口效应以及最终的宏观经济绩效联系起来的可行性。此外,鉴于抗逆转录病毒疗法和VLS在坦桑尼亚暴露人群中的临床反应,在另一个艾滋病毒高危人群较多的国家进行同样的同伴导航员干预可能会大得多。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Therapeutic Advances in Drug Safety
Therapeutic Advances in Drug Safety Medicine-Pharmacology (medical)
CiteScore
6.70
自引率
4.50%
发文量
31
审稿时长
9 weeks
期刊介绍: Therapeutic Advances in Drug Safety delivers the highest quality peer-reviewed articles, reviews, and scholarly comment on pioneering efforts and innovative studies pertaining to the safe use of drugs in patients. The journal has a strong clinical and pharmacological focus and is aimed at clinicians and researchers in drug safety, providing a forum in print and online for publishing the highest quality articles in this area. The editors welcome articles of current interest on research across all areas of drug safety, including therapeutic drug monitoring, pharmacoepidemiology, adverse drug reactions, drug interactions, pharmacokinetics, pharmacovigilance, medication/prescribing errors, risk management, ethics and regulation.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信